Posters

1A genome wide CRISPR/Cas9 screen for activators of dendritic cells

1A genome wide CRISPR/Cas9 screen for activators of dendritic cells

2CRISPR-Cas9 Gene Editing of CDK5RAP2 in Human Pluripotent Stem Cells, Derivation of Genetically Stable Clonal Lines And Formation of Cerebral Organoids Using The Stemdiff™ Human Cerebral Organoid Culture System

3Homology-directed safe harbour insertion of transgenes encoding full-length dystrophin through high-capacity adenoviral vector delivery of CRISPR-Cas9 nucleases and donor DNA

4Detection of Endogenous Protein Turnover Induced by Targeted Degraders

5Modulation of DNA repair pathways by HDR-CRISPR promotes seamless genome editing in primary human hematopoietic cells

5Modulation of DNA repair pathways by HDR-CRISPR promotes seamless genome editing in primary human hematopoietic cells

6Cellaca MX A Novel Instrument for High Throughput High Speed Cell Counting Concentration and Viability

7Genome-wide CRISPR-Cas9 screening identify key nodes regulating the NLRP3 Inflammasome

7Genome-wide CRISPR-Cas9 screening identify key nodes regulating the NLRP3 Inflammasome

8Forward Genetic Screening and Single Cell Analysis with CRISPRi Transcriptional Repressors

9Modulation of the DNA Damage Response to Enhance Targeted Integration at CRISPR/Cas9-mediated DNA Double Strand Breaks

10Functional Genomic Screening with CRISPR technologies

11Development of screening in CD4+ T cells to identify drug targets for immune-mediated inflammatory diseases

11Development of screening in CD4+ T cells to identify drug targets for immune-mediated inflammatory diseases

12Comparison of methods to study gene-to-gene variation of HDR promoting inhibitor effects

13What do people think about genetic engineering: a systematic review of post-CRISPR questionnaires

14CRISPR/Cas9 screening at the CRISPR-based Functional Genomics facility, SciLifeLab

15Optimized PAR2 assay using HT-29 PAR1 KO cells generated by CRISPR

16CRISPR KO in HSPCs to evaluate hemetox target safety liabilities: proof of concept

17Bleomycin exhibits dual inhibition towards amyloid aggregation in β-amyloid and hIAPP